Sebi imposes Rs 40 lakh penalty on Ankur Drugs

27 Aug 2013 Evaluate

Securities and Exchange Board of India (Sebi) has imposed a penalty of Rs 40 lakh on Ankur Drugs and Pharma for its failure to make quarterly disclosures to the NSE about the shares pledged by promoters as was required under the takeover norms.

As per the takeover norms, if the aggregate number of pledged shares of a promoter or every person forming part of promoter group taken together with shares already pledged during that quarter by such promoter or persons exceeds twenty five thousand or 1% of total shareholding of the company, then the company is necessary to disclose such details to the concerned stock exchanges within 7 working days.

The company has failed to make quarterly disclosures to NSE in respect of the aggregate number of shares pledged/ encumbered by the promoters during the quarters ending March 2010 to December 2011, which was in excess of 25,000 shares or 1% of the total share capital of the notice.

Peers
Company Name CMP
Sun Pharma Inds. 1751.65
Dr. Reddys Lab 1337.45
Cipla 1443.55
Lupin 2126.05
Zydus Lifesciences 983.35
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.